The early union of 17-hydroxyprogesterone with LH: FSH in the cluster analysis suggests that the PCOS phenotype may be driven by variants in genes controlling the adrenal enzyme pathway, a pathology referred to as prenatal “androgenization of the hypothalamic pituitary ovarian axis” (40). This evidence concerns the gene BRD2 and polycystic ovary syndrome.